(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDVIEW

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDVIEW

ST13

US500000087247097

Class

9, 42

Filing

87247097

Registration

6039548

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

50

Latest update

04/29/2025

Trademark type

Word

Nice classes

9, 42

Filing date

11/23/2016

Registration date

04/28/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/28/2020

Last transaction

04/29/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Abbotsford, AU

Examiner

YONTEF, DAVID

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Fred IT Group Pty Ltd

Representatives

Lorraine Linford Cozen O'Connor

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Computer software for managing medication information of userssoftware for periodically providing patients with consolidated lists and reminders of medications being used and dosages associated therewith and comparing new medication orders to medications previously taken by patients

Class 42

Providing temporary use of on-line non-downloadable software for managing medication information of userssoftware for periodically providing patients with consolidated lists and reminders of medications being used and dosages associated therewith and comparing new medication orders to medications previously taken by patients

Publications

History of USPTO decisions and trademark events.

50 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/28/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

04/28/2020

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

03/24/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

03/16/2020

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

03/16/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/24/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/30/2019

PUBO

PUBLISHED FOR OPPOSITION

07/30/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/10/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/24/2019

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

06/13/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/07/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/07/2019

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

12/11/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/12/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/11/2018

GNSL

LETTER OF SUSPENSION E-MAILED

06/11/2018

CNSL

SUSPENSION LETTER WRITTEN

06/11/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

06/11/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/11/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

06/11/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/11/2018

DPCC

DIVISIONAL PROCESSING COMPLETE

06/11/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/07/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/06/2018

DRRR

DIVISIONAL REQUEST RECEIVED

06/05/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/05/2018

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

06/05/2018

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

06/05/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/19/2018

GNSL

LETTER OF SUSPENSION E-MAILED

04/19/2018

CNSL

SUSPENSION LETTER WRITTEN

04/19/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/20/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/19/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/19/2018

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

10/07/2017

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

10/07/2017

EPEN

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

10/07/2017

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

10/07/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/13/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/13/2017

ALIE

ASSIGNED TO LIE

09/11/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/31/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/02/2017

GNRT

NON-FINAL ACTION E-MAILED

03/02/2017

CNRT

NON-FINAL ACTION WRITTEN

03/02/2017

DOCK

ASSIGNED TO EXAMINER

02/28/2017

MPMK

NOTICE OF PSEUDO MARK E-MAILED

12/02/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/01/2016

NWAP

NEW APPLICATION ENTERED

11/26/2016

Continuous trademark protection

Get notified about every new filing that threatens MEDVIEW or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.